nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—CYP26A1—embryo—sarcoma	0.0186	0.0784	CbGeAlD
Acitretin—RARA—mammary gland—sarcoma	0.0116	0.0487	CbGeAlD
Acitretin—RBP1—embryo—sarcoma	0.0111	0.0468	CbGeAlD
Acitretin—RBP1—smooth muscle tissue—sarcoma	0.00873	0.0368	CbGeAlD
Acitretin—RBP1—skin of body—sarcoma	0.00862	0.0363	CbGeAlD
Acitretin—CYP26A1—liver—sarcoma	0.0086	0.0363	CbGeAlD
Acitretin—RARA—myometrium—sarcoma	0.0082	0.0345	CbGeAlD
Acitretin—RBP1—cardiac atrium—sarcoma	0.00753	0.0317	CbGeAlD
Acitretin—RBP1—uterus—sarcoma	0.00749	0.0316	CbGeAlD
Acitretin—RARG—hematopoietic system—sarcoma	0.00748	0.0315	CbGeAlD
Acitretin—RARA—hematopoietic system—sarcoma	0.00704	0.0297	CbGeAlD
Acitretin—ALB—mammary gland—sarcoma	0.00651	0.0274	CbGeAlD
Acitretin—RARG—skin of body—sarcoma	0.00651	0.0274	CbGeAlD
Acitretin—RXRB—cardiac atrium—sarcoma	0.0064	0.027	CbGeAlD
Acitretin—RARB—tendon—sarcoma	0.00607	0.0256	CbGeAlD
Acitretin—RXRG—tendon—sarcoma	0.00594	0.025	CbGeAlD
Acitretin—RARG—uterus—sarcoma	0.00565	0.0238	CbGeAlD
Acitretin—RXRB—tendon—sarcoma	0.00558	0.0235	CbGeAlD
Acitretin—RBP1—testis—sarcoma	0.00543	0.0229	CbGeAlD
Acitretin—RARA—uterus—sarcoma	0.00532	0.0224	CbGeAlD
Acitretin—RXRA—liver—sarcoma	0.00529	0.0223	CbGeAlD
Acitretin—RBP1—liver—sarcoma	0.00514	0.0217	CbGeAlD
Acitretin—RARA—lymphoid tissue—sarcoma	0.00495	0.0209	CbGeAlD
Acitretin—RARG—tendon—sarcoma	0.00495	0.0209	CbGeAlD
Acitretin—RXRG—testis—sarcoma	0.00491	0.0207	CbGeAlD
Acitretin—RARB—liver—sarcoma	0.00475	0.02	CbGeAlD
Acitretin—RARA—tendon—sarcoma	0.00466	0.0196	CbGeAlD
Acitretin—RXRB—testis—sarcoma	0.00462	0.0195	CbGeAlD
Acitretin—RARA—bone marrow—sarcoma	0.00451	0.019	CbGeAlD
Acitretin—RXRB—liver—sarcoma	0.00437	0.0184	CbGeAlD
Acitretin—RARG—testis—sarcoma	0.0041	0.0173	CbGeAlD
Acitretin—RBP1—lymph node—sarcoma	0.00394	0.0166	CbGeAlD
Acitretin—RARA—testis—sarcoma	0.00386	0.0163	CbGeAlD
Acitretin—RARA—liver—sarcoma	0.00365	0.0154	CbGeAlD
Acitretin—RARB—lymph node—sarcoma	0.00364	0.0154	CbGeAlD
Acitretin—RARG—lymph node—sarcoma	0.00297	0.0125	CbGeAlD
Acitretin—RARA—lymph node—sarcoma	0.0028	0.0118	CbGeAlD
Acitretin—ALB—testis—sarcoma	0.00217	0.00916	CbGeAlD
Acitretin—ALB—liver—sarcoma	0.00206	0.00866	CbGeAlD
Acitretin—ALB—lymph node—sarcoma	0.00158	0.00664	CbGeAlD
Acitretin—ALB—Scavenging of heme from plasma—HBA1—sarcoma	0.0015	0.0295	CbGpPWpGaD
Acitretin—RXRG—Regulation of Androgen receptor activity—FOXO1—sarcoma	0.00133	0.0259	CbGpPWpGaD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—FOXO1—sarcoma	0.00131	0.0257	CbGpPWpGaD
Acitretin—RXRB—Regulation of Androgen receptor activity—FOXO1—sarcoma	0.00125	0.0244	CbGpPWpGaD
Acitretin—RXRA—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000972	0.019	CbGpPWpGaD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—CREB1—sarcoma	0.000952	0.0186	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	0.000866	0.017	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000863	0.0169	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—FOXO1—sarcoma	0.000853	0.0167	CbGpPWpGaD
Acitretin—Body temperature increased—Dactinomycin—sarcoma	0.000834	0.00117	CcSEcCtD
Acitretin—Abdominal pain—Dactinomycin—sarcoma	0.000834	0.00117	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000827	0.0162	CbGpPWpGaD
Acitretin—Paraesthesia—Mitoxantrone—sarcoma	0.000824	0.00116	CcSEcCtD
Acitretin—Cerebrovascular accident—Doxorubicin—sarcoma	0.000822	0.00116	CcSEcCtD
Acitretin—Decreased appetite—Vincristine—sarcoma	0.000819	0.00115	CcSEcCtD
Acitretin—Cough—Etoposide—sarcoma	0.000816	0.00115	CcSEcCtD
Acitretin—Somnolence—Mitoxantrone—sarcoma	0.000816	0.00115	CcSEcCtD
Acitretin—Blood creatinine increased—Epirubicin—sarcoma	0.000816	0.00115	CcSEcCtD
Acitretin—Gastrointestinal disorder—Vincristine—sarcoma	0.000814	0.00114	CcSEcCtD
Acitretin—Fatigue—Vincristine—sarcoma	0.000812	0.00114	CcSEcCtD
Acitretin—Dyspepsia—Mitoxantrone—sarcoma	0.000808	0.00114	CcSEcCtD
Acitretin—Pain—Vincristine—sarcoma	0.000806	0.00113	CcSEcCtD
Acitretin—Constipation—Vincristine—sarcoma	0.000806	0.00113	CcSEcCtD
Acitretin—Diplopia—Doxorubicin—sarcoma	0.000806	0.00113	CcSEcCtD
Acitretin—Osteoarthritis—Doxorubicin—sarcoma	0.000806	0.00113	CcSEcCtD
Acitretin—Liver function test abnormal—Epirubicin—sarcoma	0.000804	0.00113	CcSEcCtD
Acitretin—Dry skin—Epirubicin—sarcoma	0.000798	0.00112	CcSEcCtD
Acitretin—Decreased appetite—Mitoxantrone—sarcoma	0.000798	0.00112	CcSEcCtD
Acitretin—Chest pain—Etoposide—sarcoma	0.000796	0.00112	CcSEcCtD
Acitretin—RXRG—Regulation of Androgen receptor activity—MDM2—sarcoma	0.000795	0.0156	CbGpPWpGaD
Acitretin—Migraine—Doxorubicin—sarcoma	0.000793	0.00111	CcSEcCtD
Acitretin—Fatigue—Mitoxantrone—sarcoma	0.000791	0.00111	CcSEcCtD
Acitretin—Discomfort—Etoposide—sarcoma	0.000787	0.00111	CcSEcCtD
Acitretin—Pain—Mitoxantrone—sarcoma	0.000785	0.0011	CcSEcCtD
Acitretin—Constipation—Mitoxantrone—sarcoma	0.000785	0.0011	CcSEcCtD
Acitretin—Hypersensitivity—Thiotepa—sarcoma	0.000783	0.0011	CcSEcCtD
Acitretin—Hypersensitivity—Dactinomycin—sarcoma	0.000777	0.00109	CcSEcCtD
Acitretin—Gastrointestinal pain—Vincristine—sarcoma	0.000771	0.00108	CcSEcCtD
Acitretin—Gastritis—Epirubicin—sarcoma	0.00077	0.00108	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000768	0.00108	CcSEcCtD
Acitretin—Muscular weakness—Epirubicin—sarcoma	0.000768	0.00108	CcSEcCtD
Acitretin—Asthenia—Thiotepa—sarcoma	0.000762	0.00107	CcSEcCtD
Acitretin—Infection—Etoposide—sarcoma	0.000758	0.00107	CcSEcCtD
Acitretin—Asthenia—Dactinomycin—sarcoma	0.000757	0.00106	CcSEcCtD
Acitretin—Feeling abnormal—Mitoxantrone—sarcoma	0.000756	0.00106	CcSEcCtD
Acitretin—Blood creatinine increased—Doxorubicin—sarcoma	0.000755	0.00106	CcSEcCtD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	0.000754	0.0148	CbGpPWpGaD
Acitretin—Pruritus—Thiotepa—sarcoma	0.000752	0.00106	CcSEcCtD
Acitretin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00075	0.00105	CcSEcCtD
Acitretin—RXRB—Regulation of Androgen receptor activity—MDM2—sarcoma	0.000748	0.0146	CbGpPWpGaD
Acitretin—Body temperature increased—Vincristine—sarcoma	0.000745	0.00105	CcSEcCtD
Acitretin—Abdominal pain—Vincristine—sarcoma	0.000745	0.00105	CcSEcCtD
Acitretin—Liver function test abnormal—Doxorubicin—sarcoma	0.000744	0.00105	CcSEcCtD
Acitretin—Skin disorder—Etoposide—sarcoma	0.000741	0.00104	CcSEcCtD
Acitretin—Dry skin—Doxorubicin—sarcoma	0.000738	0.00104	CcSEcCtD
Acitretin—Hyperhidrosis—Etoposide—sarcoma	0.000738	0.00104	CcSEcCtD
Acitretin—Pancreatitis—Epirubicin—sarcoma	0.000738	0.00104	CcSEcCtD
Acitretin—Urticaria—Mitoxantrone—sarcoma	0.000729	0.00102	CcSEcCtD
Acitretin—Anorexia—Etoposide—sarcoma	0.000728	0.00102	CcSEcCtD
Acitretin—Diarrhoea—Thiotepa—sarcoma	0.000727	0.00102	CcSEcCtD
Acitretin—Body temperature increased—Mitoxantrone—sarcoma	0.000725	0.00102	CcSEcCtD
Acitretin—Abdominal pain—Mitoxantrone—sarcoma	0.000725	0.00102	CcSEcCtD
Acitretin—Diarrhoea—Dactinomycin—sarcoma	0.000722	0.00101	CcSEcCtD
Acitretin—Pancytopenia—Epirubicin—sarcoma	0.000715	0.001	CcSEcCtD
Acitretin—Gastritis—Doxorubicin—sarcoma	0.000713	0.001	CcSEcCtD
Acitretin—Muscular weakness—Doxorubicin—sarcoma	0.00071	0.000998	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00071	0.000998	CcSEcCtD
Acitretin—Dysuria—Epirubicin—sarcoma	0.000704	0.000989	CcSEcCtD
Acitretin—Dizziness—Thiotepa—sarcoma	0.000703	0.000987	CcSEcCtD
Acitretin—Hypersensitivity—Vincristine—sarcoma	0.000694	0.000976	CcSEcCtD
Acitretin—RXRG—Regulation of Androgen receptor activity—JUN—sarcoma	0.000691	0.0135	CbGpPWpGaD
Acitretin—Photosensitivity reaction—Epirubicin—sarcoma	0.000687	0.000965	CcSEcCtD
Acitretin—Paraesthesia—Etoposide—sarcoma	0.000685	0.000963	CcSEcCtD
Acitretin—Weight increased—Epirubicin—sarcoma	0.000685	0.000962	CcSEcCtD
Acitretin—Pancreatitis—Doxorubicin—sarcoma	0.000683	0.000959	CcSEcCtD
Acitretin—Weight decreased—Epirubicin—sarcoma	0.000681	0.000957	CcSEcCtD
Acitretin—Somnolence—Etoposide—sarcoma	0.000679	0.000954	CcSEcCtD
Acitretin—Hypersensitivity—Mitoxantrone—sarcoma	0.000676	0.00095	CcSEcCtD
Acitretin—Asthenia—Vincristine—sarcoma	0.000676	0.00095	CcSEcCtD
Acitretin—Vomiting—Thiotepa—sarcoma	0.000676	0.000949	CcSEcCtD
Acitretin—Vomiting—Dactinomycin—sarcoma	0.000671	0.000942	CcSEcCtD
Acitretin—Rash—Thiotepa—sarcoma	0.00067	0.000942	CcSEcCtD
Acitretin—Dermatitis—Thiotepa—sarcoma	0.000669	0.000941	CcSEcCtD
Acitretin—Headache—Thiotepa—sarcoma	0.000666	0.000935	CcSEcCtD
Acitretin—Rash—Dactinomycin—sarcoma	0.000665	0.000934	CcSEcCtD
Acitretin—Decreased appetite—Etoposide—sarcoma	0.000664	0.000932	CcSEcCtD
Acitretin—Pancytopenia—Doxorubicin—sarcoma	0.000661	0.000929	CcSEcCtD
Acitretin—Gastrointestinal disorder—Etoposide—sarcoma	0.000659	0.000926	CcSEcCtD
Acitretin—Asthenia—Mitoxantrone—sarcoma	0.000658	0.000925	CcSEcCtD
Acitretin—Fatigue—Etoposide—sarcoma	0.000658	0.000925	CcSEcCtD
Acitretin—Neuropathy peripheral—Epirubicin—sarcoma	0.000658	0.000924	CcSEcCtD
Acitretin—Jaundice—Epirubicin—sarcoma	0.000654	0.000919	CcSEcCtD
Acitretin—Stomatitis—Epirubicin—sarcoma	0.000654	0.000919	CcSEcCtD
Acitretin—Constipation—Etoposide—sarcoma	0.000653	0.000917	CcSEcCtD
Acitretin—Pain—Etoposide—sarcoma	0.000653	0.000917	CcSEcCtD
Acitretin—Urinary tract infection—Epirubicin—sarcoma	0.000652	0.000916	CcSEcCtD
Acitretin—Conjunctivitis—Epirubicin—sarcoma	0.000652	0.000916	CcSEcCtD
Acitretin—Dysuria—Doxorubicin—sarcoma	0.000651	0.000915	CcSEcCtD
Acitretin—RXRB—Regulation of Androgen receptor activity—JUN—sarcoma	0.00065	0.0127	CbGpPWpGaD
Acitretin—RXRA—Regulation of Androgen receptor activity—FOXO1—sarcoma	0.000649	0.0127	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—FOXO1—sarcoma	0.000646	0.0127	CbGpPWpGaD
Acitretin—Diarrhoea—Vincristine—sarcoma	0.000645	0.000906	CcSEcCtD
Acitretin—Haematuria—Epirubicin—sarcoma	0.00064	0.000899	CcSEcCtD
Acitretin—Photosensitivity reaction—Doxorubicin—sarcoma	0.000636	0.000893	CcSEcCtD
Acitretin—Weight increased—Doxorubicin—sarcoma	0.000634	0.00089	CcSEcCtD
Acitretin—Epistaxis—Epirubicin—sarcoma	0.000633	0.000889	CcSEcCtD
Acitretin—Nausea—Thiotepa—sarcoma	0.000631	0.000887	CcSEcCtD
Acitretin—Weight decreased—Doxorubicin—sarcoma	0.00063	0.000885	CcSEcCtD
Acitretin—Sinusitis—Epirubicin—sarcoma	0.000629	0.000884	CcSEcCtD
Acitretin—Feeling abnormal—Etoposide—sarcoma	0.000629	0.000884	CcSEcCtD
Acitretin—Diarrhoea—Mitoxantrone—sarcoma	0.000628	0.000882	CcSEcCtD
Acitretin—Nausea—Dactinomycin—sarcoma	0.000626	0.00088	CcSEcCtD
Acitretin—Gastrointestinal pain—Etoposide—sarcoma	0.000624	0.000877	CcSEcCtD
Acitretin—Dizziness—Vincristine—sarcoma	0.000623	0.000876	CcSEcCtD
Acitretin—RXRG—Regulation of Androgen receptor activity—SRC—sarcoma	0.00062	0.0121	CbGpPWpGaD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—sarcoma	0.000619	0.0121	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—CREB1—sarcoma	0.000619	0.0121	CbGpPWpGaD
Acitretin—Neuropathy peripheral—Doxorubicin—sarcoma	0.000609	0.000855	CcSEcCtD
Acitretin—RARA—Adipogenesis—FOXO1—sarcoma	0.000608	0.0119	CbGpPWpGaD
Acitretin—Urticaria—Etoposide—sarcoma	0.000606	0.000852	CcSEcCtD
Acitretin—Haemoglobin—Epirubicin—sarcoma	0.000605	0.000851	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—sarcoma	0.000605	0.00085	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—sarcoma	0.000605	0.00085	CcSEcCtD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—MYC—sarcoma	0.000605	0.0118	CbGpPWpGaD
Acitretin—Rhinitis—Epirubicin—sarcoma	0.000604	0.000848	CcSEcCtD
Acitretin—Body temperature increased—Etoposide—sarcoma	0.000603	0.000848	CcSEcCtD
Acitretin—Abdominal pain—Etoposide—sarcoma	0.000603	0.000848	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—sarcoma	0.000603	0.000848	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—sarcoma	0.000603	0.000848	CcSEcCtD
Acitretin—Hepatitis—Epirubicin—sarcoma	0.000602	0.000846	CcSEcCtD
Acitretin—Haemorrhage—Epirubicin—sarcoma	0.000602	0.000846	CcSEcCtD
Acitretin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HBA1—sarcoma	0.0006	0.0118	CbGpPWpGaD
Acitretin—RXRA—PPAR Alpha Pathway—CCND1—sarcoma	0.0006	0.0117	CbGpPWpGaD
Acitretin—Hypoaesthesia—Epirubicin—sarcoma	0.000599	0.000842	CcSEcCtD
Acitretin—Vomiting—Vincristine—sarcoma	0.000599	0.000842	CcSEcCtD
Acitretin—Pharyngitis—Epirubicin—sarcoma	0.000598	0.00084	CcSEcCtD
Acitretin—Rash—Vincristine—sarcoma	0.000594	0.000835	CcSEcCtD
Acitretin—Dermatitis—Vincristine—sarcoma	0.000594	0.000834	CcSEcCtD
Acitretin—Oedema peripheral—Epirubicin—sarcoma	0.000593	0.000834	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—sarcoma	0.000592	0.000832	CcSEcCtD
Acitretin—Headache—Vincristine—sarcoma	0.00059	0.00083	CcSEcCtD
Acitretin—Epistaxis—Doxorubicin—sarcoma	0.000586	0.000823	CcSEcCtD
Acitretin—Vomiting—Mitoxantrone—sarcoma	0.000584	0.00082	CcSEcCtD
Acitretin—RXRB—Regulation of Androgen receptor activity—SRC—sarcoma	0.000583	0.0114	CbGpPWpGaD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—sarcoma	0.000582	0.0114	CbGpPWpGaD
Acitretin—Sinusitis—Doxorubicin—sarcoma	0.000582	0.000818	CcSEcCtD
Acitretin—Visual impairment—Epirubicin—sarcoma	0.00058	0.000816	CcSEcCtD
Acitretin—Rash—Mitoxantrone—sarcoma	0.000579	0.000813	CcSEcCtD
Acitretin—Dermatitis—Mitoxantrone—sarcoma	0.000578	0.000812	CcSEcCtD
Acitretin—Headache—Mitoxantrone—sarcoma	0.000575	0.000808	CcSEcCtD
Acitretin—Eye disorder—Epirubicin—sarcoma	0.000563	0.000791	CcSEcCtD
Acitretin—Hypersensitivity—Etoposide—sarcoma	0.000562	0.00079	CcSEcCtD
Acitretin—Tinnitus—Epirubicin—sarcoma	0.000562	0.000789	CcSEcCtD
Acitretin—Haemoglobin—Doxorubicin—sarcoma	0.00056	0.000787	CcSEcCtD
Acitretin—Nausea—Vincristine—sarcoma	0.00056	0.000787	CcSEcCtD
Acitretin—Flushing—Epirubicin—sarcoma	0.000559	0.000785	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—sarcoma	0.000559	0.000785	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—sarcoma	0.000557	0.000783	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—sarcoma	0.000557	0.000783	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—sarcoma	0.000554	0.000779	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—sarcoma	0.000553	0.000777	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—sarcoma	0.000549	0.000771	CcSEcCtD
Acitretin—Asthenia—Etoposide—sarcoma	0.000548	0.00077	CcSEcCtD
Acitretin—Angiopathy—Epirubicin—sarcoma	0.000546	0.000768	CcSEcCtD
Acitretin—Nausea—Mitoxantrone—sarcoma	0.000545	0.000766	CcSEcCtD
Acitretin—Immune system disorder—Epirubicin—sarcoma	0.000544	0.000764	CcSEcCtD
Acitretin—Chills—Epirubicin—sarcoma	0.00054	0.000759	CcSEcCtD
Acitretin—Pruritus—Etoposide—sarcoma	0.00054	0.000759	CcSEcCtD
Acitretin—Visual impairment—Doxorubicin—sarcoma	0.000537	0.000755	CcSEcCtD
Acitretin—RXRA—Transcriptional activation of mitochondrial biogenesis—CREB1—sarcoma	0.000537	0.0105	CbGpPWpGaD
Acitretin—Alopecia—Epirubicin—sarcoma	0.000532	0.000748	CcSEcCtD
Acitretin—Erythema—Epirubicin—sarcoma	0.000524	0.000737	CcSEcCtD
Acitretin—Diarrhoea—Etoposide—sarcoma	0.000522	0.000734	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—sarcoma	0.000521	0.000732	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—sarcoma	0.00052	0.00073	CcSEcCtD
Acitretin—Flushing—Doxorubicin—sarcoma	0.000517	0.000727	CcSEcCtD
Acitretin—Tension—Epirubicin—sarcoma	0.000514	0.000723	CcSEcCtD
Acitretin—Dysgeusia—Epirubicin—sarcoma	0.000513	0.000721	CcSEcCtD
Acitretin—Nervousness—Epirubicin—sarcoma	0.000509	0.000716	CcSEcCtD
Acitretin—Back pain—Epirubicin—sarcoma	0.000507	0.000713	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—sarcoma	0.000506	0.00071	CcSEcCtD
Acitretin—Dizziness—Etoposide—sarcoma	0.000505	0.000709	CcSEcCtD
Acitretin—ALB—Vitamin B12 Metabolism—HBA1—sarcoma	0.000504	0.00987	CbGpPWpGaD
Acitretin—Muscle spasms—Epirubicin—sarcoma	0.000504	0.000708	CcSEcCtD
Acitretin—Immune system disorder—Doxorubicin—sarcoma	0.000503	0.000707	CcSEcCtD
Acitretin—Chills—Doxorubicin—sarcoma	0.0005	0.000703	CcSEcCtD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—sarcoma	0.000497	0.00974	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—TP53—sarcoma	0.000497	0.00973	CbGpPWpGaD
Acitretin—Vision blurred—Epirubicin—sarcoma	0.000494	0.000694	CcSEcCtD
Acitretin—Alopecia—Doxorubicin—sarcoma	0.000492	0.000692	CcSEcCtD
Acitretin—Ill-defined disorder—Epirubicin—sarcoma	0.000486	0.000684	CcSEcCtD
Acitretin—Vomiting—Etoposide—sarcoma	0.000485	0.000682	CcSEcCtD
Acitretin—Erythema—Doxorubicin—sarcoma	0.000485	0.000682	CcSEcCtD
Acitretin—Rash—Etoposide—sarcoma	0.000481	0.000676	CcSEcCtD
Acitretin—RXRA—PPAR Alpha Pathway—MYC—sarcoma	0.000481	0.00942	CbGpPWpGaD
Acitretin—Dermatitis—Etoposide—sarcoma	0.000481	0.000676	CcSEcCtD
Acitretin—Headache—Etoposide—sarcoma	0.000478	0.000672	CcSEcCtD
Acitretin—Tension—Doxorubicin—sarcoma	0.000476	0.000669	CcSEcCtD
Acitretin—Dysgeusia—Doxorubicin—sarcoma	0.000475	0.000668	CcSEcCtD
Acitretin—Malaise—Epirubicin—sarcoma	0.000473	0.000664	CcSEcCtD
Acitretin—Nervousness—Doxorubicin—sarcoma	0.000471	0.000662	CcSEcCtD
Acitretin—Back pain—Doxorubicin—sarcoma	0.000469	0.000659	CcSEcCtD
Acitretin—RXRG—Adipogenesis—CREB1—sarcoma	0.000469	0.00918	CbGpPWpGaD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—sarcoma	0.000468	0.00916	CbGpPWpGaD
Acitretin—Muscle spasms—Doxorubicin—sarcoma	0.000466	0.000655	CcSEcCtD
Acitretin—RXRA—Mitochondrial biogenesis—CREB1—sarcoma	0.000464	0.00908	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000458	0.00897	CbGpPWpGaD
Acitretin—Cough—Epirubicin—sarcoma	0.000458	0.000643	CcSEcCtD
Acitretin—RXRA—Circadian Clock—CREB1—sarcoma	0.000457	0.00895	CbGpPWpGaD
Acitretin—Vision blurred—Doxorubicin—sarcoma	0.000457	0.000642	CcSEcCtD
Acitretin—Nausea—Etoposide—sarcoma	0.000453	0.000637	CcSEcCtD
Acitretin—Ill-defined disorder—Doxorubicin—sarcoma	0.00045	0.000632	CcSEcCtD
Acitretin—Chest pain—Epirubicin—sarcoma	0.000446	0.000627	CcSEcCtD
Acitretin—Arthralgia—Epirubicin—sarcoma	0.000446	0.000627	CcSEcCtD
Acitretin—Myalgia—Epirubicin—sarcoma	0.000446	0.000627	CcSEcCtD
Acitretin—Anxiety—Epirubicin—sarcoma	0.000445	0.000625	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—CTNNB1—sarcoma	0.000442	0.00865	CbGpPWpGaD
Acitretin—Discomfort—Epirubicin—sarcoma	0.000441	0.00062	CcSEcCtD
Acitretin—RARA—Adipogenesis—CREB1—sarcoma	0.000441	0.00863	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000439	0.0086	CbGpPWpGaD
Acitretin—Malaise—Doxorubicin—sarcoma	0.000437	0.000615	CcSEcCtD
Acitretin—Dry mouth—Epirubicin—sarcoma	0.000437	0.000613	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000431	0.00844	CbGpPWpGaD
Acitretin—Oedema—Epirubicin—sarcoma	0.000428	0.000601	CcSEcCtD
Acitretin—Infection—Epirubicin—sarcoma	0.000425	0.000597	CcSEcCtD
Acitretin—Cough—Doxorubicin—sarcoma	0.000423	0.000595	CcSEcCtD
Acitretin—Skin disorder—Epirubicin—sarcoma	0.000416	0.000584	CcSEcCtD
Acitretin—Hyperhidrosis—Epirubicin—sarcoma	0.000414	0.000581	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—sarcoma	0.000413	0.00058	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—sarcoma	0.000413	0.00058	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—sarcoma	0.000413	0.00058	CcSEcCtD
Acitretin—Anxiety—Doxorubicin—sarcoma	0.000412	0.000578	CcSEcCtD
Acitretin—ALB—Folate Metabolism—HBA1—sarcoma	0.00041	0.00803	CbGpPWpGaD
Acitretin—Discomfort—Doxorubicin—sarcoma	0.000408	0.000573	CcSEcCtD
Acitretin—Anorexia—Epirubicin—sarcoma	0.000408	0.000573	CcSEcCtD
Acitretin—Dry mouth—Doxorubicin—sarcoma	0.000404	0.000568	CcSEcCtD
Acitretin—RARG—Gene Expression—FUS—sarcoma	0.000401	0.00784	CbGpPWpGaD
Acitretin—Oedema—Doxorubicin—sarcoma	0.000396	0.000556	CcSEcCtD
Acitretin—Infection—Doxorubicin—sarcoma	0.000393	0.000553	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00039	0.000548	CcSEcCtD
Acitretin—RXRA—Regulation of Androgen receptor activity—MDM2—sarcoma	0.00039	0.00763	CbGpPWpGaD
Acitretin—Insomnia—Epirubicin—sarcoma	0.000387	0.000544	CcSEcCtD
Acitretin—Skin disorder—Doxorubicin—sarcoma	0.000385	0.00054	CcSEcCtD
Acitretin—Paraesthesia—Epirubicin—sarcoma	0.000384	0.00054	CcSEcCtD
Acitretin—Hyperhidrosis—Doxorubicin—sarcoma	0.000383	0.000538	CcSEcCtD
Acitretin—ALB—Platelet degranulation—VEGFC—sarcoma	0.000382	0.00748	CbGpPWpGaD
Acitretin—Somnolence—Epirubicin—sarcoma	0.00038	0.000535	CcSEcCtD
Acitretin—Anorexia—Doxorubicin—sarcoma	0.000377	0.00053	CcSEcCtD
Acitretin—Dyspepsia—Epirubicin—sarcoma	0.000377	0.000529	CcSEcCtD
Acitretin—Decreased appetite—Epirubicin—sarcoma	0.000372	0.000523	CcSEcCtD
Acitretin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000369	0.000519	CcSEcCtD
Acitretin—Fatigue—Epirubicin—sarcoma	0.000369	0.000518	CcSEcCtD
Acitretin—RXRG—Gene Expression—FUS—sarcoma	0.000366	0.00717	CbGpPWpGaD
Acitretin—Pain—Epirubicin—sarcoma	0.000366	0.000514	CcSEcCtD
Acitretin—Constipation—Epirubicin—sarcoma	0.000366	0.000514	CcSEcCtD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.000364	0.00713	CbGpPWpGaD
Acitretin—RBP1—Disease—TLE1—sarcoma	0.000363	0.00711	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000361	0.000507	CcSEcCtD
Acitretin—RARB—Gene Expression—FUS—sarcoma	0.000359	0.00704	CbGpPWpGaD
Acitretin—Insomnia—Doxorubicin—sarcoma	0.000358	0.000503	CcSEcCtD
Acitretin—Paraesthesia—Doxorubicin—sarcoma	0.000356	0.0005	CcSEcCtD
Acitretin—Feeling abnormal—Epirubicin—sarcoma	0.000353	0.000495	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—sarcoma	0.000352	0.000495	CcSEcCtD
Acitretin—RXRA—Developmental Biology—MYOG—sarcoma	0.000351	0.00687	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Epirubicin—sarcoma	0.00035	0.000492	CcSEcCtD
Acitretin—Dyspepsia—Doxorubicin—sarcoma	0.000349	0.00049	CcSEcCtD
Acitretin—RXRB—Gene Expression—FUS—sarcoma	0.000345	0.00675	CbGpPWpGaD
Acitretin—RARA—Gene Expression—FUS—sarcoma	0.000345	0.00675	CbGpPWpGaD
Acitretin—Decreased appetite—Doxorubicin—sarcoma	0.000344	0.000484	CcSEcCtD
Acitretin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000342	0.00048	CcSEcCtD
Acitretin—Fatigue—Doxorubicin—sarcoma	0.000341	0.00048	CcSEcCtD
Acitretin—Urticaria—Epirubicin—sarcoma	0.00034	0.000478	CcSEcCtD
Acitretin—RXRA—Regulation of Androgen receptor activity—JUN—sarcoma	0.000339	0.00663	CbGpPWpGaD
Acitretin—Constipation—Doxorubicin—sarcoma	0.000339	0.000476	CcSEcCtD
Acitretin—Pain—Doxorubicin—sarcoma	0.000339	0.000476	CcSEcCtD
Acitretin—Abdominal pain—Epirubicin—sarcoma	0.000338	0.000475	CcSEcCtD
Acitretin—Body temperature increased—Epirubicin—sarcoma	0.000338	0.000475	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000338	0.00662	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—CTNNB1—sarcoma	0.000335	0.00655	CbGpPWpGaD
Acitretin—RBP1—Disease—NPM1—sarcoma	0.000327	0.00641	CbGpPWpGaD
Acitretin—Feeling abnormal—Doxorubicin—sarcoma	0.000326	0.000458	CcSEcCtD
Acitretin—ALB—Selenium Micronutrient Network—HBA1—sarcoma	0.000326	0.00638	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000324	0.00634	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000324	0.000455	CcSEcCtD
Acitretin—RXRA—Adipogenesis—FOXO1—sarcoma	0.000317	0.0062	CbGpPWpGaD
Acitretin—Hypersensitivity—Epirubicin—sarcoma	0.000315	0.000443	CcSEcCtD
Acitretin—RARA—Adipogenesis—CTNNB1—sarcoma	0.000315	0.00616	CbGpPWpGaD
Acitretin—Urticaria—Doxorubicin—sarcoma	0.000315	0.000442	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—sarcoma	0.000313	0.00044	CcSEcCtD
Acitretin—Body temperature increased—Doxorubicin—sarcoma	0.000313	0.00044	CcSEcCtD
Acitretin—Asthenia—Epirubicin—sarcoma	0.000307	0.000431	CcSEcCtD
Acitretin—RXRA—Regulation of Androgen receptor activity—SRC—sarcoma	0.000304	0.00595	CbGpPWpGaD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—sarcoma	0.000304	0.00594	CbGpPWpGaD
Acitretin—Pruritus—Epirubicin—sarcoma	0.000303	0.000425	CcSEcCtD
Acitretin—Diarrhoea—Epirubicin—sarcoma	0.000293	0.000411	CcSEcCtD
Acitretin—Hypersensitivity—Doxorubicin—sarcoma	0.000292	0.00041	CcSEcCtD
Acitretin—Asthenia—Doxorubicin—sarcoma	0.000284	0.000399	CcSEcCtD
Acitretin—RBP1—Disease—ENO2—sarcoma	0.000284	0.00555	CbGpPWpGaD
Acitretin—Dizziness—Epirubicin—sarcoma	0.000283	0.000398	CcSEcCtD
Acitretin—Pruritus—Doxorubicin—sarcoma	0.00028	0.000394	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.00028	0.00548	CbGpPWpGaD
Acitretin—Vomiting—Epirubicin—sarcoma	0.000272	0.000382	CcSEcCtD
Acitretin—Diarrhoea—Doxorubicin—sarcoma	0.000271	0.000381	CcSEcCtD
Acitretin—Rash—Epirubicin—sarcoma	0.00027	0.000379	CcSEcCtD
Acitretin—Dermatitis—Epirubicin—sarcoma	0.00027	0.000379	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000268	0.00525	CbGpPWpGaD
Acitretin—Headache—Epirubicin—sarcoma	0.000268	0.000377	CcSEcCtD
Acitretin—RXRA—Developmental Biology—EZR—sarcoma	0.000266	0.00521	CbGpPWpGaD
Acitretin—Dizziness—Doxorubicin—sarcoma	0.000262	0.000368	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—TLE1—sarcoma	0.000254	0.00498	CbGpPWpGaD
Acitretin—Nausea—Epirubicin—sarcoma	0.000254	0.000357	CcSEcCtD
Acitretin—Vomiting—Doxorubicin—sarcoma	0.000252	0.000354	CcSEcCtD
Acitretin—Rash—Doxorubicin—sarcoma	0.00025	0.000351	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—sarcoma	0.000249	0.00035	CcSEcCtD
Acitretin—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	0.000249	0.00488	CbGpPWpGaD
Acitretin—Headache—Doxorubicin—sarcoma	0.000248	0.000349	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—sarcoma	0.000244	0.00477	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000244	0.00477	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000243	0.00476	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000241	0.00472	CbGpPWpGaD
Acitretin—RBP1—Disease—PLCG1—sarcoma	0.000241	0.00471	CbGpPWpGaD
Acitretin—Nausea—Doxorubicin—sarcoma	0.000235	0.00033	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000234	0.00457	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000233	0.00456	CbGpPWpGaD
Acitretin—RBP1—Disease—CXCR4—sarcoma	0.000231	0.00453	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000231	0.00453	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—CREB1—sarcoma	0.00023	0.0045	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000229	0.00448	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000218	0.00427	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MYOD1—sarcoma	0.000217	0.00425	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFC—sarcoma	0.000215	0.0042	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000212	0.00416	CbGpPWpGaD
Acitretin—RXRA—Organelle biogenesis and maintenance—CREB1—sarcoma	0.000211	0.00412	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000209	0.00409	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000204	0.00399	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000195	0.00383	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ENO2—sarcoma	0.000194	0.00379	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—HBA1—sarcoma	0.000192	0.00377	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000191	0.00374	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000187	0.00367	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000183	0.00359	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000181	0.00353	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—FUS—sarcoma	0.00018	0.00352	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000173	0.00339	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FLT1—sarcoma	0.000171	0.00336	CbGpPWpGaD
Acitretin—RBP1—Disease—FOXO1—sarcoma	0.000171	0.00334	CbGpPWpGaD
Acitretin—RBP1—Disease—PDGFRB—sarcoma	0.00017	0.00334	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.000169	0.00332	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000169	0.00331	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PLCG1—sarcoma	0.000169	0.0033	CbGpPWpGaD
Acitretin—RBP1—Disease—PDGFRA—sarcoma	0.000168	0.00329	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PLCG1—sarcoma	0.000164	0.00322	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—CTNNB1—sarcoma	0.000164	0.00321	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CXCR4—sarcoma	0.000162	0.00317	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.00016	0.00314	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ATF1—sarcoma	0.00016	0.00314	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PTPRC—sarcoma	0.000157	0.00307	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000154	0.00301	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—PLCG1—sarcoma	0.000153	0.003	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.00014	0.00274	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL2—sarcoma	0.000133	0.00261	CbGpPWpGaD
Acitretin—RBP1—Disease—KIT—sarcoma	0.00013	0.00255	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IGF1R—sarcoma	0.000126	0.00246	CbGpPWpGaD
Acitretin—RBP1—Disease—CREB1—sarcoma	0.000124	0.00243	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000122	0.00238	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000121	0.00238	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000121	0.00236	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—FOXO1—sarcoma	0.00012	0.00234	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PDGFRB—sarcoma	0.000119	0.00234	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TEK—sarcoma	0.000119	0.00233	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PDGFRA—sarcoma	0.000118	0.0023	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000109	0.00213	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—FOXO1—sarcoma	0.000109	0.00213	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ANGPT2—sarcoma	0.000109	0.00213	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—MYC—sarcoma	0.000108	0.00212	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000106	0.00208	CbGpPWpGaD
Acitretin—RBP1—Disease—MDM2—sarcoma	0.000102	0.00201	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—MYC—sarcoma	9.9e-05	0.00194	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KDR—sarcoma	9.89e-05	0.00194	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	9.76e-05	0.00191	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—VEGFA—sarcoma	9.71e-05	0.0019	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—MYC—sarcoma	9.71e-05	0.0019	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	9.55e-05	0.00187	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—MYC—sarcoma	9.31e-05	0.00182	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—MYC—sarcoma	9.31e-05	0.00182	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	9.25e-05	0.00181	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KIT—sarcoma	9.11e-05	0.00178	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	9.02e-05	0.00177	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KDR—sarcoma	9.01e-05	0.00176	CbGpPWpGaD
Acitretin—RBP1—Disease—CTNNB1—sarcoma	8.84e-05	0.00173	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFC—sarcoma	8.74e-05	0.00171	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CREB1—sarcoma	8.68e-05	0.0017	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TP53—sarcoma	8.56e-05	0.00168	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	8.02e-05	0.00157	CbGpPWpGaD
Acitretin—RBP1—Disease—SRC—sarcoma	7.99e-05	0.00156	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CREB1—sarcoma	7.9e-05	0.00155	CbGpPWpGaD
Acitretin—RBP1—Disease—NRAS—sarcoma	7.69e-05	0.00151	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MMP2—sarcoma	7.35e-05	0.00144	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ENO2—sarcoma	7.19e-05	0.00141	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MDM2—sarcoma	7.18e-05	0.00141	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—sarcoma	7.16e-05	0.0014	CbGpPWpGaD
Acitretin—RXRA—Metabolism—HBA1—sarcoma	7.15e-05	0.0014	CbGpPWpGaD
Acitretin—RBP1—Disease—EGFR—sarcoma	7e-05	0.00137	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PLCG1—sarcoma	6.87e-05	0.00134	CbGpPWpGaD
Acitretin—RBP1—Disease—KRAS—sarcoma	6.62e-05	0.0013	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2—sarcoma	6.41e-05	0.00126	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCND1—sarcoma	6.25e-05	0.00122	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—JUN—sarcoma	6.24e-05	0.00122	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CTNNB1—sarcoma	6.19e-05	0.00121	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PLCG1—sarcoma	6.1e-05	0.00119	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CTNNB1—sarcoma	5.64e-05	0.0011	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—sarcoma	5.62e-05	0.0011	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SRC—sarcoma	5.6e-05	0.0011	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VEGFA—sarcoma	5.45e-05	0.00107	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NRAS—sarcoma	5.38e-05	0.00105	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—sarcoma	5.21e-05	0.00102	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—SRC—sarcoma	5.09e-05	0.000997	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	5.07e-05	0.000992	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—sarcoma	5.01e-05	0.000982	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—VEGFA—sarcoma	4.96e-05	0.000971	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—EGFR—sarcoma	4.9e-05	0.00096	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NRAS—sarcoma	4.9e-05	0.000959	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—sarcoma	4.85e-05	0.000949	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—sarcoma	4.76e-05	0.000933	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—sarcoma	4.67e-05	0.000915	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—KRAS—sarcoma	4.63e-05	0.000907	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—sarcoma	4.48e-05	0.000877	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—sarcoma	4.48e-05	0.000877	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—EGFR—sarcoma	4.46e-05	0.000874	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	4.42e-05	0.000866	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	4.31e-05	0.000843	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—KRAS—sarcoma	4.22e-05	0.000826	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—sarcoma	4.12e-05	0.000806	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—sarcoma	3.94e-05	0.000771	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—sarcoma	3.59e-05	0.000702	CbGpPWpGaD
Acitretin—ALB—Metabolism—ENO2—sarcoma	3.28e-05	0.000642	CbGpPWpGaD
Acitretin—ALB—Metabolism—HBA1—sarcoma	3.26e-05	0.000638	CbGpPWpGaD
Acitretin—ALB—Metabolism—PLCG1—sarcoma	2.78e-05	0.000545	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2—sarcoma	2.61e-05	0.000511	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—sarcoma	2.33e-05	0.000457	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SRC—sarcoma	2.28e-05	0.000446	CbGpPWpGaD
Acitretin—ALB—Hemostasis—VEGFA—sarcoma	2.22e-05	0.000435	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NRAS—sarcoma	2.19e-05	0.000429	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KRAS—sarcoma	1.89e-05	0.000369	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—sarcoma	1.68e-05	0.000328	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—sarcoma	1.6e-05	0.000314	CbGpPWpGaD
